Bourantas, K L <br/><br/>
Combination therapy with interferon alfa-2b and hydroxyurea during the accelerated phase of chronic myelogenous leukemia.  [electronic resource] 

 -  Acta haematologica  1996 
 - 117-21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0001-5792 
<br/><br/><label>Standard No.: </label>10.1159/000203859  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Female<br/>Humans<br/>Hydroxyurea--administration & dosage<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Leukemia, Myeloid, Accelerated Phase--drug therapy<br/>Male<br/>Middle Aged<br/>Recombinant Proteins